Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancerVitor H. Almeida, Robson Q. Monteiro|Oncotarget|2018Cited by 45
Radiotherapy modulates expression of EGFR, ERCC1 and p53 in cervical cancerVitor H. Almeida, Cinthya Sternberg|Brazilian Journal of Medical and Biological Research|2017Cited by 24